Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Eton Pharmaceuticals (ETON) Leases (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Leases for 7 consecutive years, with $310000.0 as the latest value for Q4 2025.

  • Quarterly Leases rose 77.14% to $310000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $310000.0 through Dec 2025, up 77.14% year-over-year, with the annual reading at $310000.0 for FY2025, 77.14% up from the prior year.
  • Leases hit $310000.0 in Q4 2025 for Eton Pharmaceuticals, down from $319000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $324000.0 in Q2 2025 to a low of $71000.0 in Q1 2022.
  • Historically, Leases has averaged $159300.0 across 5 years, with a median of $146000.0 in 2021.
  • Biggest five-year swings in Leases: tumbled 50.35% in 2022 and later surged 138.03% in 2023.
  • Year by year, Leases stood at $104000.0 in 2021, then surged by 80.77% to $188000.0 in 2022, then tumbled by 45.21% to $103000.0 in 2023, then surged by 69.9% to $175000.0 in 2024, then soared by 77.14% to $310000.0 in 2025.
  • Business Quant data shows Leases for ETON at $310000.0 in Q4 2025, $319000.0 in Q3 2025, and $324000.0 in Q2 2025.